ResMed Inc. (RMD) Financials
RMD Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 9.0 billion | 2.4 billion |
| March 31, 2026 | 8.8 billion | 2.3 billion |
| Dec. 31, 2025 | 8.5 billion | 2.2 billion |
| Sept. 30, 2025 | 8.3 billion | 2.2 billion |
RMD Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 1.6 billion | 104.3 million |
| March 31, 2026 | 520.5 million | 26.8 million |
| Dec. 31, 2025 | 305.2 million | 28.9 million |
| Sept. 30, 2025 | 414.4 million | 21.2 million |
RMD Net Income
| Date | Net Income |
|---|---|
| June 30, 2026 | 1.5 billion |
| March 31, 2026 | 398.7 million |
| Dec. 31, 2025 | 392.6 million |
| Sept. 30, 2025 | 348.5 million |
RMD Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 1.5 billion | 399.4 million | 137.4 million |
| March 31, 2026 | 1.7 billion | 404.2 million | 179.1 million |
| Dec. 31, 2025 | 1.4 billion | 558.1 million | 154.1 million |
| Sept. 30, 2025 | 1.4 billion | 408.7 million | 177.8 million |
RMD Shares Outstanding
RMD Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 156.3 million | 105.7 million | 290.7 million | - |
| March 31, 2026 | 33.7 million | 94.3 million | 279.8 million | - |
| Dec. 31, 2025 | 34.6 million | 91.0 million | 278.4 million | - |
| Sept. 30, 2025 | 43.0 million | 87.3 million | 259.2 million | - |
RMD Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 1.5 billion | 602.4 million |
| March 31, 2026 | 1.4 billion | 540.4 million |
| Dec. 31, 2025 | 1.4 billion | 538.1 million |
| Sept. 30, 2025 | 1.3 billion | 514.8 million |
RMD Revenue by Segment
RMD
Price: $224.99
Dividend Yield: 1.08%
Forward Dividend Yield: 1.17%
Payout Ratio: 30.59%
Dividend Per Share: 2.64 USD
Earnings Per Share: 10.66 USD
P/E Ratio: 21.09
Exchange: NYQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States
Volume: 1.2 million
Ebitda: 178.5 millionMarket Capitalization: 33.1 billion
Average Dividend Frequency: 4
Years Paying Dividends: 15
DGR3: 8.83%
DGR5: 7.07%
DGR10: 6.78%